A MULTICENTER PHASE I-II STUDY OF TOSEDOSTAT IN THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA

被引：0
|
作者：
Ossenkoppele, G. [1 ]
Hooftman, W. [2 ]
Zweegman, S. [1 ]
Davies, E. [3 ]
Morgan, G. [3 ]
Mueller-Tidow, C. [4 ]
Krug, U. [4 ]
Duhrsen, U. [4 ]
Burnett, A. [5 ]
Jenkins, C. [5 ]
Zachee, P. [6 ]
Dierickx, D. [4 ]
Lowenberg, B. [7 ]
Sonneveld, P. [7 ]
Hooftman, L. [2 ]
Richardson, A. [2 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Chroma Therapeut Ltd, Oxford, England
[3] Royal Marsden Hosp, London SW3 6JJ, England
[4] Univ Hosp, Munster, Germany
[5] Cardiff Univ Hosp, Cardiff, S Glam, Wales
[6] ZNA, Antwerp, Belgium
[7] Erasmus MC, Rotterdam, Netherlands
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1065
引用
收藏
页码：429 / 429
页数：1
相关论文
共 50 条
  • [41] A phase I study of ENMD-2076 in patients with relapsed or refractory acute myeloid leukemia (AML)
    Yee, Karen W.
    Brandwein, Joseph
    Minden, Mark D.
    Sanfelice, Deborah
    Chow, Sue
    Hedley, David W.
    Schimmer, Aaron D.
    Schuh, Andre C.
    Gupta, Vikas
    Sidor, Carolyn F.
    Arnott, Jamie
    Fletcher, Graham
    Bray, Mark
    Chen, Hsiao-Wei Tina
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [42] Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia
    Naohiro Sekiguchi
    Senji Kasahara
    Toshihiro Miyamoto
    Toru Kiguchi
    Hitoshi Ohno
    Taiga Takagi
    Masaya Tachibana
    Hiroyuki Sumi
    Yasuyuki Kakurai
    Tomonari Yamashita
    Kensuke Usuki
    International Journal of Hematology, 2023, 117 : 68 - 77
  • [43] A phase I-II pilot study of divalproex sodium alone and in combination with all-trans-retinoic acid (ATRA) in relapsed or refractory acute myeloid leukemia
    Gabrilove, JL
    McConnell, MJ
    Berkofsky-Fessler, W
    Sirulnik, AL
    Sharma, S
    Silverman, LR
    Isola, L
    Mandeli, J
    Licht, J
    BLOOD, 2005, 106 (11) : 785A - 785A
  • [44] Phase I/II Study of Clofarabine, Etoposide, and Mitoxantrone in Patients With Refractory or Relapsed Acute Leukemia
    Abbi, Kamal K. S.
    Rybka, Witold
    Ehmann, W. Christopher
    Claxton, David F.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (01): : 41 - 46
  • [45] Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia
    Walker, Alison R.
    Klisovic, Rebecca B.
    Garzon, Ramiro
    Schaaf, Larry J.
    Humphries, Kristina
    Devine, Steven M.
    Byrd, John C.
    Grever, Michael R.
    Marcucci, Guido
    Blum, William
    LEUKEMIA & LYMPHOMA, 2014, 55 (06) : 1304 - 1308
  • [46] Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study.
    Vey, N
    Kantarjian, H
    Beran, M
    O'Brien, S
    Cortes, J
    Giles, FJ
    Koller, C
    Estey, E
    BLOOD, 1998, 92 (10) : 235A - 235A
  • [47] A Phase I/II Study of the Janus Kinase (JAK)1 and 2 Inhibitor Ruxolitinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Pemmaraju, Naveen
    Kantarjian, Hagop
    Kadia, Tapan
    Cortes, Jorge
    Borthakur, Gautam
    Newberry, Kate
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Jabbour, Elias
    Dellasala, Sara
    Pierce, Sherry
    Verstovsek, Srdan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (03): : 171 - 176
  • [48] A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia
    Abdel-Karim, Isam
    Plunkett, William K., Jr.
    O'Brien, Susan
    Giles, Francis
    Thomas, Deborah
    Faderl, Stefan
    Ravandi, Farhad
    Rios, Mary Beth
    Du, Min
    Schneck, Karen B.
    Chen, Victor J.
    Lin, Boris K.
    Nicol, Steven J.
    Kantarjian, Hagop M.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (02) : 323 - 331
  • [49] Phase I study of sorafenib in patients with refractory or relapsed acute leukemias
    Borthakur, Gautam
    Kantarjian, Hagop
    Ravandi, Farhad
    Zhang, Weiguo
    Konopleva, Marina
    Wright, John J.
    Faderl, Stefan
    Verstovsek, Srdan
    Mathews, Sheela
    Andreeff, Michael
    Cortes, Jorge E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (01): : 62 - 68
  • [50] A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia
    Isam Abdel-Karim
    William K. Plunkett
    Susan O’Brien
    Francis Giles
    Deborah Thomas
    Stefan Faderl
    Farhad Ravandi
    Mary Beth Rios
    Min Du
    Karen B. Schneck
    Victor J. Chen
    Boris K. Lin
    Steven J. Nicol
    Hagop M. Kantarjian
    Investigational New Drugs, 2011, 29 : 323 - 331
12345